{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:13:10Z","timestamp":1720609990314},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.compbiolchem.2017.09.012","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T02:46:27Z","timestamp":1506566787000},"page":"63-69","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessment of in vivo organ-uptake and in silico prediction of CYP mediated metabolism of DA-Phen, a new dopaminergic agent"],"prefix":"10.1016","volume":"71","author":[{"given":"Flavia Maria","family":"Sutera","sequence":"first","affiliation":[]},{"given":"Libero Italo","family":"Giannola","sequence":"additional","affiliation":[]},{"given":"Denise","family":"Murgia","sequence":"additional","affiliation":[]},{"given":"Viviana","family":"De Caro","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-2614(89)85118-8","article-title":"Electronic-Structure calculations on workstation computers; the program system turbomole","volume":"162","author":"Ahlrichs","year":"1989","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0010","first-page":"25","article-title":"Glycosyl derivatives of Dopamine and L-Dopa as antiparkinson prodrugs: synthesis, pharmacological activity and in vitro stability studies","volume":"11","author":"Bonina","year":"2003","journal-title":"J. Drug Targeting"},{"issue":"November (11)","key":"10.1016\/j.compbiolchem.2017.09.012_bib0015","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","article-title":"A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance","volume":"5","author":"Calabresi","year":"2006","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.compbiolchem.2017.09.012_bib0020","first-page":"632","article-title":"Attention-deficit hyperactivity disorder","volume":"9","author":"Calis","year":"1990","journal-title":"Clin. Pharm."},{"issue":"3","key":"10.1016\/j.compbiolchem.2017.09.012_bib0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/08982100903384129","article-title":"Potential dopamine prodrug-loaded liposomes: preparation, characterization, and in vitro stability studies","volume":"20","author":"Carafa","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/157340611794072733","article-title":"N-Valproyl-L-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug","volume":"7","author":"De Caro","year":"2011","journal-title":"Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573406410666140507094954","article-title":"N-Valproyl-L-Phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy","volume":"11","author":"De Caro","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0040","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/1061186X.2015.1035275","article-title":"Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation","volume":"23","author":"De Caro","year":"2015","journal-title":"J. Drug Targeting"},{"issue":"4","key":"10.1016\/j.compbiolchem.2017.09.012_bib0045","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/jm051145p","article-title":"L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties","volume":"49","author":"Di Stefano","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2017.09.012_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ki.1989.178","article-title":"Dopamine receptor subtypes in renal brush border and basolateral membranes","volume":"36","author":"Felder","year":"1989","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.compbiolchem.2017.09.012_bib0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0008-6215(00)00073-2","article-title":"Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents","volume":"327","author":"Fern\u00e1ndez","year":"2000","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0060","first-page":"829","article-title":"Synthesis and characterization of aminoacidic pro-drugs of valproic acid","volume":"53","author":"Giannola","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0065","first-page":"704","article-title":"Synthesis and in vitro studies on a potential dopamine prodrug","volume":"63","author":"Giannola","year":"2008","journal-title":"Pharmazie"},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"October (5335)","key":"10.1016\/j.compbiolchem.2017.09.012_bib0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.compbiolchem.2017.09.012_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2008.09.018","article-title":"Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen","volume":"206","author":"Mignini","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.compbiolchem.2017.09.012_bib0085","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/jm070037v","article-title":"Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties","volume":"50","author":"Pinnen","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0090","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/jm070037v","article-title":"Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties","volume":"50","author":"Pinnen","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00726-010-0804-z","article-title":"CNS delivery of L-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug","volume":"42","author":"Pinnen","year":"2012","journal-title":"Amino Acids"},{"issue":"1\u20132","key":"10.1016\/j.compbiolchem.2017.09.012_bib0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10641969709080804","article-title":"Expression of dopamine receptors in immune organs and circulating immune cells","volume":"19","author":"Ricci","year":"1997","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0105","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/bioinformatics\/btq584","article-title":"The SMARTCyp cytochrome P450 metabolism prediction server","volume":"26","author":"Rydberg","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0110","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/anie.201206207","article-title":"A- nitrogen inversion barriers affect the N-Oxidation of tertiary alkylamines by cytochromes P450","volume":"52","author":"Rydberg","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0115","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/mp3005116","article-title":"The contribution of atom accessibility to site of metabolism models for cytochromes P450","volume":"10","author":"Rydberg","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0120","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00702-012-0814-y","article-title":"Inhibitory effects of N-valproyl-L-tryptophan on high potassium, low calcium and low magnesium-induced CA1 hippocampal epileptiform bursting activity in rat brain slices","volume":"119","author":"Sardo","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0125","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3892\/ijo.2013.2115","article-title":"Oligodendrioma cells synthesyze the differentiation-specific linker histone H1 and release i tinto the extracellular environment through shed vesicles","volume":"43","author":"Schiera","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/17460441.2012.677025","article-title":"Designing prodrugs for the treatment of Parkinson's disease","volume":"7","author":"Sozio","year":"2012","journal-title":"Expert. Opin. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/ci025584y","article-title":"The chemistry development kit (CDK): an open-Source java library for chemo- and bioinformatics","volume":"43","author":"Steinbeck","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0140","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2174\/138161206777585274","article-title":"Recent developments of the Chemistry Development Kit (CDK) \u2212 An open-source Java library for chemo- and bioinformatics","volume":"12","author":"Steinbeck","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2016.05.006","article-title":"Effects of DA-Phen, a dopamine-aminoacidic conjugate","volume":"310","author":"Sutera","year":"2016","journal-title":"Alcohol. Intake Forced Abstinence Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.compbiolchem.2017.09.012_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/17425247.2016.1208651","article-title":"Small endogenous molecules as moiety to improve targeting of CNS drugs","volume":"14","author":"Sutera","year":"2016","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejmech.2016.08.051","article-title":"Design, synthesis and preliminary evaluation of dopamine-amino acid conjugates as potential D1 dopaminergic modulators","volume":"124","author":"Tutone Chinnici","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.012_bib0160","series-title":"Biological Basis of Neurological and Psychiatric Disorders","article-title":"Neurobiology of brain disorders","author":"Zigmond","year":"2014"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927117300166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927117300166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T14:54:20Z","timestamp":1538664860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927117300166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"alternative-id":["S1476927117300166"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2017.09.012","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of in vivo organ-uptake and in silico prediction of CYP mediated metabolism of DA-Phen, a new dopaminergic agent","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2017.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}